Scientists at Newcastle University have developed a groundbreaking 3D bioprinting technique to improve drug discovery. The method creates human-like tissue models, enhancing drug testing accuracy and reducing failure rates. Backed by Versus Arthritis, the innovation has led to a spin-out company, Jetbio, aiming to revolutionise lab research worldwide.